Physician

Adam Daniel Paronish, FNP-C, CRNP

According to 2025 Medicare claims, Adam Paronish, FNP-C, CRNP (NPI: 1518524008) practices nurse practitioner in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is CARING HEALTHCARE NETWORK (NPI: 1417260266; TIN: 274133844) and primary practice location at 16866-9998.

Paronish's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 79 traditional Medicare patients, billed 1,027 HCPCS/CPT codes, and received $92,615 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,544 prescription claims across 304 beneficiaries totaling $132,576 in drug costs, led by Xtampza Er (Oxycodone Myristate). Open Payments data shows 22 records totaling $408. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,554 to $92,615. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	52	79	$5,554
2020	240	793	$46,886
2021	168	942	$64,665
2022	181	1,312	$105,686
2023	142	1,446	$137,678
2024	79	1,027	$92,615

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	185	741	$40,463
2020	465	3,635	$174,179
2021	360	2,644	$127,838
2022	381	2,841	$150,640
2023	444	3,377	$172,169
2024	304	2,544	$132,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	35	81	$195
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	49	158	$153
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	11	11	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	70	426	$70
80307	Testing for presence of drug, by chemistry analyzers	61	350	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	45	1,327	$34,948
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	567	16,839	$15,393
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	646	19,057	$14,903
Oxycontin	Oxycodone Hcl	34	1,020	$14,278
Belbuca	Buprenorphine Hcl	20	600	$10,393

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$408	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Daniel Paronish, FNP-C, CRNP?

Tedicare shows public-source Medicare data for Adam Daniel Paronish, FNP-C, CRNP (NPI 1518524008), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Daniel Paronish, FNP-C, CRNP have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Daniel Paronish, FNP-C, CRNP?

Adam Daniel Paronish, FNP-C, CRNP is linked to CARING HEALTHCARE NETWORK (billing NPI 1417260266) in the available physician profile data.

Does Adam Daniel Paronish, FNP-C, CRNP have Open Payments data?

Adam Daniel Paronish, FNP-C, CRNP has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.